ACHILLION PHARMACEUTICALS INC

Profile

Company Names

ACHILLION PHARMACEUTICALS INC

Addresses

300 GEORGE STREET, NEW HAVEN, CT 06511

Phone Numbers

203-624-7000

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$50,105,162.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2010-08-20 
$50,105,162.00 
$50,105,162.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MILIND 
S. 
DESHPANDE 
EXECUTIVE OFFICER
ACHILLION PHARMACEUTICALS INC
MARY KAY 
 
FENTON 
EXECUTIVE OFFICER
ACHILLION PHARMACEUTICALS INC   |  ONCORUS, INC.
JASON 
S. 
FISHERMAN 
DIRECTOR
ACHILLION PHARMACEUTICALS INC
GARY 
E. 
FRASHIER 
DIRECTOR
ALSERES PHARMACEUTICALS INC /DE   |  ACHILLION PHARMACEUTICALS INC
MICHAEL 
 
GREY 
DIRECTOR
AUSPEX PHARMACEUTICALS, INC.   |  ACHILLION PHARMACEUTICALS INC   |  LUMENA PHARMACEUTICALS, INC.   |  SELVENTA, INC.   |  HORIZON PHARMA, INC.   |  BALANCE THERAPEUTICS, INC.   |  AMPLYX PHARMACEUTICALS, INC.   |  RENEO PHARMACEUTICALS, INC.   |  MIRUM PHARMACEUTICALS, INC.   |  SPRUCE BIOSCIENCES, INC.   |  SORRISO PHARMACEUTICALS, INC.   |  PLEXIUM, INC.
MICHAEL 
D. 
KISHBAUCH 
EXECUTIVE OFFICER, DIRECTOR
ACHILLION PHARMACEUTICALS INC   |  CATABASIS PHARMACEUTICALS INC
DENNIS 
C. 
LIOTTA 
DIRECTOR
ACHILLION PHARMACEUTICALS INC
ELIZABETH 
 
OLEK 
EXECUTIVE OFFICER
ACHILLION PHARMACEUTICALS INC
DAVID 
I. 
SCHEER 
DIRECTOR
OPTHERION INC   |  AXERION THERAPEUTICS, INC.   |  ACHILLION PHARMACEUTICALS INC
GAUTAM 
 
SHAH 
EXECUTIVE OFFICER
ACHILLION PHARMACEUTICALS INC   |  PRODIGY VENTURES, INC.   |  MUX, INC.   |  KAMERRA JAGUAR, LLC   |  KAMERRA JELLYFISH, LLC   |  KAMERRA TIGER, LLC   |  KAMERRA JELLYFISH 2 LLC   |  KAMERRA LYNX LLC   |  KAMERRA WOLF LLC   |  KAMERRA TIGER 2, LLC   |  KCP ORCA HOLDINGS, LLC   |  KAMERRA PONY, LLC   |  KAMERRA STALLION, LLC
NICHOLAS 
J. 
SIMON 
DIRECTOR
ACHILLION PHARMACEUTICALS INC   |  PEARL THERAPEUTICS INC   |  CLARUS LIFESCIENCES III, L.P.   |  CLARUS DEFINED EXIT I, L.P.   |  CLARUS DE II, L.P.   |  CLARUS IV-D, L.P.   |  CLARUS IV-C, L.P.   |  CLARUS IV-B, L.P.   |  CLARUS IV-A, L.P.
JOSEPH 
 
TRUITT 
EXECUTIVE OFFICER
ACHILLION PHARMACEUTICALS INC   |  LARIMAR THERAPEUTICS, INC.   |  CODE BIOTHERAPEUTICS, INC.
ROBERT 
L. 
VAN NOSTRAND 
DIRECTOR
ACHILLION PHARMACEUTICALS INC   |  METABOLIX, INC.   |  ENUMERAL BIOMEDICAL HOLDINGS, INC.   |  YIELD10 BIOSCIENCE, INC.   |  SELLAS LIFE SCIENCES GROUP, INC.
DAVID 
P. 
WRIGHT 
DIRECTOR
PHARMATHENE, INC   |  ACHILLION PHARMACEUTICALS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2010-08-23
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2010-08-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#